vuwodu.wordpress.com
The non-exclusive licensing agreement was signedwith Biken, the nonprofi t operational arm of the Foundation for Microbial Diseases of Osakz University. The deal also included funding suppor t for bird flu vaccine development from the National Institute of Infectiousz Diseasesof Japan. Hemispherx (AMEX:HEB) will received royalties and income for all Ampligen suppliee used in the ongoing experimental work and any subsequent marketing of Ampligemn to improve the performance of intranasal fluvacciner products.
Hemispherx is developing Ampligen as a treatment for chronic Last week, the Food and Drug Administratioj informed the company its new drug applicatiom for Ampligen, which has been in development for threer decades, was insufficiently complete. Hemispherx is working with the FDA to addressdits concerns.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment